Newsletter registration

Dynamic Business Location.

Apeiron Biologics gets a EUR 25 million loan from EIB

Apeiron CEO H. Loibner © Apeiron Biologics

The funds are designed to help the company develop new pharmaceutical products for the treatment of cancer, especially rare types affecting children. The financing for Apeiron was made possible by the “European Fund for Strategic Investments” (EFSI).

Apeiron was founded in 2003 by the geneticist Josef Penninger, the scientific director of the Institute for Molecular Biology (IMBA) in Vienna. In May 2017, the European Commission granted market approval for a therapy focusing on immunotherapy of neuroblastoma. The therapy should increase the survival and chances of recovery for the serious cancer neuroblastoma which affects children at an early age. It is a rare cancer, but is responsible for up to 10% of solid tumors in childhood, affecting about 1,200 children in the EU and USA every year.  

Share on Facebook Share on Facebook Share on Twitter Share on Twitter



Meet us at events, seminars and trade shows - worldwide.

  • Meet us at: Cyber Security Event at the University of South Bohemia

    22.03.2018, České Budějovice, Czech Republic

  • Cégalapítás és vállalkozásindítás Ausztriában

    17.04.2018, Sopron, Hungary

Austria Map

Find the perfect location for your company

The "mental closeness" of Austria to its neighbours is an important advantage for establishing new business contacts.

Ericsson Austria

More testimonials

news from the business location Austria

Practical solutions in the “Competence Center for Digital Production”

The "Austrian Competence Center for Digital Production (ACDP)" considers itself to be an interdisciplinary service provider in the field of research and development and presented the range of its activities at its kick-off event.

Cyber security is a Hype – Justifiably So?

Digitalization makes it essential to conduct research into new methods and develop new technologies as protection against cyberattacks. Several fundamental measures are justified more than ever before.

More news All blog posts